Ok
Cancel
Don't show this message again
-
Ok CancelDon't show this message again
Can Your Hospital's Controlled Substance Diversion Prevention Efforts Withstand Government Scrutiny?
Amy Boring, Attorney, King & Spalding LLP. Shannon Cox, Counsel, King & Spalding LLP. Steve Cummings, Attorney, Kind & Spalding LLP.
June 10, 2021
-
Why hospitals are at risk for controlled substance diversion
-
What can trigger DEA scrutiny
-
Key elements of a controlled substance diversion prevention program in a hospital setting
-
The questions to ask now to prepare your controlled substance diversion prevention program for government scrutiny
-